HEADER IMMUNE SYSTEM 29-AUG-17 6ATZ TITLE HLA-DRB1*1402 IN COMPLEX WITH CITRULLINATED FIBRINOGEN PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS II HISTOCOMPATIBILITY ANTIGEN, DR ALPHA CHAIN; COMPND 3 CHAIN: A, C; COMPND 4 FRAGMENT: UNP RESIDUES 29-205; COMPND 5 SYNONYM: MHC CLASS II ANTIGEN DRA; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: MHC CLASS II ANTIGEN; COMPND 9 CHAIN: B, D; COMPND 10 FRAGMENT: UNP RESIDUES 32-219; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: FIBRINOGEN BETA CHAIN; COMPND 14 CHAIN: E, F; COMPND 15 FRAGMENT: RESIDUES 69-81; COMPND 16 SYNONYM: FIBRINOGEN BETA- 74CIT69-81; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-DRA, HLA-DRA1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: HLA-DRB1; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI 'BL21-GOLD(DE3)PLYSS AG'; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 866768; SOURCE 15 MOL_ID: 3; SOURCE 16 SYNTHETIC: YES; SOURCE 17 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 18 ORGANISM_COMMON: HUMAN; SOURCE 19 ORGANISM_TAXID: 9606 KEYWDS HLA, MHC, CITRULLINE, RHEUMATOID ARTHRITIS, IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR Y.T.TING,S.W.SCALLY,J.ROSSJOHN REVDAT 5 15-NOV-23 6ATZ 1 LINK ATOM REVDAT 4 04-OCT-23 6ATZ 1 HETSYN REVDAT 3 29-JUL-20 6ATZ 1 COMPND REMARK HETNAM LINK REVDAT 3 2 1 SITE REVDAT 2 18-OCT-17 6ATZ 1 JRNL REVDAT 1 20-SEP-17 6ATZ 0 JRNL AUTH S.W.SCALLY,S.C.LAW,Y.T.TING,J.V.HEEMST,J.SOKOLOVE, JRNL AUTH 2 A.J.DEUTSCH,E.BRIDIE CLEMENS,A.K.MOUSTAKAS,G.K.PAPADOPOULOS, JRNL AUTH 3 D.V.WOUDE,I.SMOLIK,C.A.HITCHON,D.B.ROBINSON,E.D.FERUCCI, JRNL AUTH 4 C.N.BERNSTEIN,X.MENG,V.ANAPARTI,T.HUIZINGA,K.KEDZIERSKA, JRNL AUTH 5 H.H.REID,S.RAYCHAUDHURI,R.E.TOES,J.ROSSJOHN,H.EL-GABALAWY, JRNL AUTH 6 R.THOMAS JRNL TITL MOLECULAR BASIS FOR INCREASED SUSCEPTIBILITY OF INDIGENOUS JRNL TITL 2 NORTH AMERICANS TO SEROPOSITIVE RHEUMATOID ARTHRITIS. JRNL REF ANN. RHEUM. DIS. V. 76 1915 2017 JRNL REFN ISSN 1468-2060 JRNL PMID 28801345 JRNL DOI 10.1136/ANNRHEUMDIS-2017-211300 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.48 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 24007 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.201 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.610 REMARK 3 FREE R VALUE TEST SET COUNT : 1106 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.4846 - 5.3975 0.99 2928 170 0.2131 0.2168 REMARK 3 2 5.3975 - 4.2852 1.00 2859 157 0.1602 0.1859 REMARK 3 3 4.2852 - 3.7438 0.99 2868 148 0.1715 0.2135 REMARK 3 4 3.7438 - 3.4017 0.99 2858 125 0.1938 0.2593 REMARK 3 5 3.4017 - 3.1579 0.99 2863 115 0.2214 0.2545 REMARK 3 6 3.1579 - 2.9718 0.99 2847 137 0.2342 0.3220 REMARK 3 7 2.9718 - 2.8230 0.99 2833 140 0.2614 0.3715 REMARK 3 8 2.8230 - 2.7001 0.99 2845 114 0.2547 0.3308 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.870 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 39.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.83 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 6322 REMARK 3 ANGLE : 0.572 8608 REMARK 3 CHIRALITY : 0.044 934 REMARK 3 PLANARITY : 0.003 1115 REMARK 3 DIHEDRAL : 14.582 3656 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN B AND (RESID 3 THROUGH 21 OR REMARK 3 (RESID 22 THROUGH 23 AND (NAME N OR NAME REMARK 3 CA OR NAME C OR NAME O OR NAME CB )) OR REMARK 3 RESID 24 THROUGH 34 OR (RESID 35 AND REMARK 3 (NAME N OR NAME CA OR NAME C OR NAME O OR REMARK 3 NAME CB )) OR RESID 36 THROUGH 51 OR REMARK 3 RESID 53 THROUGH 97 OR RESID 99 THROUGH REMARK 3 137 OR (RESID 138 AND (NAME N OR NAME CA REMARK 3 OR NAME C OR NAME O OR NAME CB )) OR REMARK 3 RESID 139 THROUGH 161 OR RESID 163 REMARK 3 THROUGH 167 OR RESID 169 THROUGH 190)) REMARK 3 SELECTION : (CHAIN D AND (RESID 3 THROUGH 51 OR RESID REMARK 3 53 THROUGH 97 OR RESID 99 THROUGH 161 OR REMARK 3 RESID 163 THROUGH 188 OR (RESID 189 REMARK 3 THROUGH 190 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )))) REMARK 3 ATOM PAIRS NUMBER : 2247 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6ATZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-17. REMARK 100 THE DEPOSITION ID IS D_1000229813. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-APR-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24028 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 47.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : 0.12800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.00 REMARK 200 R MERGE FOR SHELL (I) : 0.48100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4MCY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% PEG3350, 0.2 M POTASSIUM NITRATE, REMARK 280 0.1 M BIS-TRIS PROPANE, PH 7.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 36.44250 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7450 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17870 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17720 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY D 168 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 40 CG CD OE1 OE2 REMARK 470 GLU A 46 CG CD OE1 OE2 REMARK 470 ARG A 100 CG CD NE CZ NH1 NH2 REMARK 470 THR A 130 OG1 CG2 REMARK 470 ARG B 23 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 65 CG CD CE NZ REMARK 470 LYS B 105 CG CD CE NZ REMARK 470 LEU B 109 CG CD1 CD2 REMARK 470 GLN B 110 CG CD OE1 NE2 REMARK 470 ARG B 189 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 38 CG CD CE NZ REMARK 470 LYS C 39 CG CD CE NZ REMARK 470 GLU C 40 CG CD OE1 OE2 REMARK 470 GLU C 46 CG CD OE1 OE2 REMARK 470 GLU C 71 CG CD OE1 OE2 REMARK 470 ARG C 100 CG CD NE CZ NH1 NH2 REMARK 470 GLU C 141 CG CD OE1 OE2 REMARK 470 ASP C 171 CG OD1 OD2 REMARK 470 GLU C 172 CG CD OE1 OE2 REMARK 470 GLU D 22 CG CD OE1 OE2 REMARK 470 ARG D 23 CG CD NE CZ NH1 NH2 REMARK 470 GLU D 35 CG CD OE1 OE2 REMARK 470 GLU D 52 CG CD OE1 OE2 REMARK 470 LYS D 65 CG CD CE NZ REMARK 470 LYS D 105 CG CD CE NZ REMARK 470 LEU D 109 CG CD1 CD2 REMARK 470 GLN D 110 CG CD OE1 NE2 REMARK 470 GLU D 138 CG CD OE1 OE2 REMARK 470 LYS E 8 CG CD CE NZ REMARK 470 LYS F 8 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 ND2 ASN C 78 O5 NAG C 201 1.95 REMARK 500 CG ASN A 78 C1 NAG A 201 2.06 REMARK 500 O HOH B 313 O HOH B 317 2.08 REMARK 500 ND2 ASN A 78 C2 NAG A 201 2.17 REMARK 500 OD1 ASN A 78 C1 NAG A 201 2.19 REMARK 500 O HOH A 329 O HOH B 311 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OD2 ASP B 76 NH1 ARG B 166 1455 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CIR E 5 O - C - N ANGL. DEV. = -16.3 DEGREES REMARK 500 PRO E 6 C - N - CD ANGL. DEV. = -13.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 100 15.32 58.95 REMARK 500 HIS A 143 3.03 58.83 REMARK 500 ASN B 33 -113.84 59.05 REMARK 500 THR B 90 -65.35 -128.97 REMARK 500 HIS B 112 96.80 -64.78 REMARK 500 ASN D 33 -113.03 57.08 REMARK 500 THR D 90 -64.96 -130.02 REMARK 500 HIS D 112 95.97 -67.20 REMARK 500 ALA F 10 -179.32 -68.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 ALA E 4 17.91 REMARK 500 CIR E 5 -18.03 REMARK 500 ALA F 4 12.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6ATI RELATED DB: PDB REMARK 900 RELATED ID: 6ATF RELATED DB: PDB DBREF 6ATZ A 4 180 UNP P01903 DRA_HUMAN 29 205 DBREF1 6ATZ B 3 190 UNP A0A0A1I7H6_HUMAN DBREF2 6ATZ B A0A0A1I7H6 32 219 DBREF 6ATZ C 4 180 UNP P01903 DRA_HUMAN 29 205 DBREF1 6ATZ D 3 190 UNP A0A0A1I7H6_HUMAN DBREF2 6ATZ D A0A0A1I7H6 32 219 DBREF 6ATZ E 0 11 PDB 6ATZ 6ATZ 0 11 DBREF 6ATZ F 0 11 PDB 6ATZ 6ATZ 0 11 SEQRES 1 A 177 GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR LEU ASN PRO SEQRES 2 A 177 ASP GLN SER GLY GLU PHE MET PHE ASP PHE ASP GLY ASP SEQRES 3 A 177 GLU ILE PHE HIS VAL ASP MET ALA LYS LYS GLU THR VAL SEQRES 4 A 177 TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SER PHE GLU SEQRES 5 A 177 ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL ASP LYS ALA SEQRES 6 A 177 ASN LEU GLU ILE MET THR LYS ARG SER ASN TYR THR PRO SEQRES 7 A 177 ILE THR ASN VAL PRO PRO GLU VAL THR VAL LEU THR ASN SEQRES 8 A 177 SER PRO VAL GLU LEU ARG GLU PRO ASN VAL LEU ILE CYS SEQRES 9 A 177 PHE ILE ASP LYS PHE THR PRO PRO VAL VAL ASN VAL THR SEQRES 10 A 177 TRP LEU ARG ASN GLY LYS PRO VAL THR THR GLY VAL SER SEQRES 11 A 177 GLU THR VAL PHE LEU PRO ARG GLU ASP HIS LEU PHE ARG SEQRES 12 A 177 LYS PHE HIS TYR LEU PRO PHE LEU PRO SER THR GLU ASP SEQRES 13 A 177 VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY LEU ASP GLU SEQRES 14 A 177 PRO LEU LEU LYS HIS TRP GLU PHE SEQRES 1 B 188 THR ARG PRO ARG PHE LEU GLU TYR SER THR SER GLU CYS SEQRES 2 B 188 HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE LEU GLU SEQRES 3 B 188 ARG TYR PHE HIS ASN GLN GLU GLU ASN VAL ARG PHE ASP SEQRES 4 B 188 SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU LEU GLY SEQRES 5 B 188 ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS ASP LEU SEQRES 6 B 188 LEU GLU GLN ARG ARG ALA ALA VAL ASP THR TYR CYS ARG SEQRES 7 B 188 HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL GLN ARG SEQRES 8 B 188 ARG VAL HIS PRO LYS VAL THR VAL TYR PRO SER LYS THR SEQRES 9 B 188 GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SER VAL SEQRES 10 B 188 SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG TRP PHE SEQRES 11 B 188 ARG ASN GLY GLN GLU GLU LYS THR GLY VAL VAL SER THR SEQRES 12 B 188 GLY LEU ILE HIS ASN GLY ASP TRP THR PHE GLN THR LEU SEQRES 13 B 188 VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU VAL TYR SEQRES 14 B 188 THR CYS GLN VAL GLU HIS PRO SER VAL THR SER PRO LEU SEQRES 15 B 188 THR VAL GLU TRP ARG ALA SEQRES 1 C 177 GLU HIS VAL ILE ILE GLN ALA GLU PHE TYR LEU ASN PRO SEQRES 2 C 177 ASP GLN SER GLY GLU PHE MET PHE ASP PHE ASP GLY ASP SEQRES 3 C 177 GLU ILE PHE HIS VAL ASP MET ALA LYS LYS GLU THR VAL SEQRES 4 C 177 TRP ARG LEU GLU GLU PHE GLY ARG PHE ALA SER PHE GLU SEQRES 5 C 177 ALA GLN GLY ALA LEU ALA ASN ILE ALA VAL ASP LYS ALA SEQRES 6 C 177 ASN LEU GLU ILE MET THR LYS ARG SER ASN TYR THR PRO SEQRES 7 C 177 ILE THR ASN VAL PRO PRO GLU VAL THR VAL LEU THR ASN SEQRES 8 C 177 SER PRO VAL GLU LEU ARG GLU PRO ASN VAL LEU ILE CYS SEQRES 9 C 177 PHE ILE ASP LYS PHE THR PRO PRO VAL VAL ASN VAL THR SEQRES 10 C 177 TRP LEU ARG ASN GLY LYS PRO VAL THR THR GLY VAL SER SEQRES 11 C 177 GLU THR VAL PHE LEU PRO ARG GLU ASP HIS LEU PHE ARG SEQRES 12 C 177 LYS PHE HIS TYR LEU PRO PHE LEU PRO SER THR GLU ASP SEQRES 13 C 177 VAL TYR ASP CYS ARG VAL GLU HIS TRP GLY LEU ASP GLU SEQRES 14 C 177 PRO LEU LEU LYS HIS TRP GLU PHE SEQRES 1 D 188 THR ARG PRO ARG PHE LEU GLU TYR SER THR SER GLU CYS SEQRES 2 D 188 HIS PHE PHE ASN GLY THR GLU ARG VAL ARG PHE LEU GLU SEQRES 3 D 188 ARG TYR PHE HIS ASN GLN GLU GLU ASN VAL ARG PHE ASP SEQRES 4 D 188 SER ASP VAL GLY GLU TYR ARG ALA VAL THR GLU LEU GLY SEQRES 5 D 188 ARG PRO ASP ALA GLU TYR TRP ASN SER GLN LYS ASP LEU SEQRES 6 D 188 LEU GLU GLN ARG ARG ALA ALA VAL ASP THR TYR CYS ARG SEQRES 7 D 188 HIS ASN TYR GLY VAL GLY GLU SER PHE THR VAL GLN ARG SEQRES 8 D 188 ARG VAL HIS PRO LYS VAL THR VAL TYR PRO SER LYS THR SEQRES 9 D 188 GLN PRO LEU GLN HIS HIS ASN LEU LEU VAL CYS SER VAL SEQRES 10 D 188 SER GLY PHE TYR PRO GLY SER ILE GLU VAL ARG TRP PHE SEQRES 11 D 188 ARG ASN GLY GLN GLU GLU LYS THR GLY VAL VAL SER THR SEQRES 12 D 188 GLY LEU ILE HIS ASN GLY ASP TRP THR PHE GLN THR LEU SEQRES 13 D 188 VAL MET LEU GLU THR VAL PRO ARG SER GLY GLU VAL TYR SEQRES 14 D 188 THR CYS GLN VAL GLU HIS PRO SER VAL THR SER PRO LEU SEQRES 15 D 188 THR VAL GLU TRP ARG ALA SEQRES 1 E 12 GLY GLY TYR ARG ALA CIR PRO ALA LYS ALA ALA THR SEQRES 1 F 12 GLY GLY TYR ARG ALA CIR PRO ALA LYS ALA ALA THR MODRES 6ATZ CIR E 5 ARG MODIFIED RESIDUE MODRES 6ATZ CIR F 5 ARG MODIFIED RESIDUE HET CIR E 5 22 HET CIR F 5 22 HET NAG A 201 27 HET NAG A 202 27 HET B3P B 201 45 HET NAG C 201 27 HET NAG C 202 27 HETNAM CIR CITRULLINE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM B3P 2-[3-(2-HYDROXY-1,1-DIHYDROXYMETHYL-ETHYLAMINO)- HETNAM 2 B3P PROPYLAMINO]-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 5 CIR 2(C6 H13 N3 O3) FORMUL 7 NAG 4(C8 H15 N O6) FORMUL 9 B3P C11 H26 N2 O6 FORMUL 12 HOH *112(H2 O) HELIX 1 AA1 LEU A 45 ARG A 50 1 6 HELIX 2 AA2 GLU A 55 SER A 77 1 23 HELIX 3 AA3 THR B 51 LEU B 53 5 3 HELIX 4 AA4 GLY B 54 SER B 63 1 10 HELIX 5 AA5 GLN B 64 ALA B 73 1 10 HELIX 6 AA6 ALA B 73 TYR B 78 1 6 HELIX 7 AA7 TYR B 78 GLY B 86 1 9 HELIX 8 AA8 GLU B 87 THR B 90 5 4 HELIX 9 AA9 LEU C 45 PHE C 51 5 7 HELIX 10 AB1 GLU C 55 SER C 77 1 23 HELIX 11 AB2 THR D 51 LEU D 53 5 3 HELIX 12 AB3 GLY D 54 SER D 63 1 10 HELIX 13 AB4 GLN D 64 ALA D 73 1 10 HELIX 14 AB5 ALA D 73 TYR D 78 1 6 HELIX 15 AB6 TYR D 78 GLY D 86 1 9 HELIX 16 AB7 GLU D 87 THR D 90 5 4 SHEET 1 AA1 8 GLU A 40 TRP A 43 0 SHEET 2 AA1 8 ASP A 29 ASP A 35 -1 N HIS A 33 O VAL A 42 SHEET 3 AA1 8 SER A 19 PHE A 26 -1 N PHE A 26 O ASP A 29 SHEET 4 AA1 8 HIS A 5 ASN A 15 -1 N ILE A 8 O ASP A 25 SHEET 5 AA1 8 PHE B 7 PHE B 18 -1 O PHE B 17 N HIS A 5 SHEET 6 AA1 8 ARG B 23 HIS B 32 -1 O ARG B 25 N HIS B 16 SHEET 7 AA1 8 GLU B 35 ASP B 41 -1 O ASN B 37 N TYR B 30 SHEET 8 AA1 8 TYR B 47 ALA B 49 -1 O ARG B 48 N ARG B 39 SHEET 1 AA2 4 GLU A 88 THR A 93 0 SHEET 2 AA2 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA2 4 PHE A 145 PHE A 153 -1 O LEU A 151 N LEU A 105 SHEET 4 AA2 4 SER A 133 GLU A 134 -1 N SER A 133 O TYR A 150 SHEET 1 AA3 4 GLU A 88 THR A 93 0 SHEET 2 AA3 4 ASN A 103 PHE A 112 -1 O ILE A 106 N LEU A 92 SHEET 3 AA3 4 PHE A 145 PHE A 153 -1 O LEU A 151 N LEU A 105 SHEET 4 AA3 4 LEU A 138 PRO A 139 -1 N LEU A 138 O ARG A 146 SHEET 1 AA4 4 LYS A 126 VAL A 128 0 SHEET 2 AA4 4 ASN A 118 ARG A 123 -1 N ARG A 123 O LYS A 126 SHEET 3 AA4 4 TYR A 161 GLU A 166 -1 O ARG A 164 N THR A 120 SHEET 4 AA4 4 LEU A 174 TRP A 178 -1 O TRP A 178 N TYR A 161 SHEET 1 AA5 4 LYS B 98 SER B 104 0 SHEET 2 AA5 4 LEU B 114 PHE B 122 -1 O LEU B 114 N SER B 104 SHEET 3 AA5 4 PHE B 155 GLU B 162 -1 O THR B 157 N VAL B 119 SHEET 4 AA5 4 VAL B 142 SER B 144 -1 N VAL B 143 O MET B 160 SHEET 1 AA6 4 LYS B 98 SER B 104 0 SHEET 2 AA6 4 LEU B 114 PHE B 122 -1 O LEU B 114 N SER B 104 SHEET 3 AA6 4 PHE B 155 GLU B 162 -1 O THR B 157 N VAL B 119 SHEET 4 AA6 4 ILE B 148 HIS B 149 -1 N ILE B 148 O GLN B 156 SHEET 1 AA7 4 GLN B 136 GLU B 138 0 SHEET 2 AA7 4 GLU B 128 ARG B 133 -1 N ARG B 133 O GLN B 136 SHEET 3 AA7 4 VAL B 170 GLU B 176 -1 O GLN B 174 N ARG B 130 SHEET 4 AA7 4 LEU B 184 ARG B 189 -1 O LEU B 184 N VAL B 175 SHEET 1 AA8 8 GLU C 40 TRP C 43 0 SHEET 2 AA8 8 ASP C 29 ASP C 35 -1 N HIS C 33 O VAL C 42 SHEET 3 AA8 8 SER C 19 PHE C 26 -1 N PHE C 26 O ASP C 29 SHEET 4 AA8 8 HIS C 5 ASN C 15 -1 N ALA C 10 O MET C 23 SHEET 5 AA8 8 PHE D 7 PHE D 18 -1 O CYS D 15 N ILE C 7 SHEET 6 AA8 8 ARG D 23 HIS D 32 -1 O ARG D 25 N HIS D 16 SHEET 7 AA8 8 GLU D 35 ASP D 41 -1 O ASN D 37 N TYR D 30 SHEET 8 AA8 8 TYR D 47 ALA D 49 -1 O ARG D 48 N ARG D 39 SHEET 1 AA9 4 GLU C 88 THR C 93 0 SHEET 2 AA9 4 ASN C 103 PHE C 112 -1 O ILE C 106 N LEU C 92 SHEET 3 AA9 4 PHE C 145 PHE C 153 -1 O HIS C 149 N CYS C 107 SHEET 4 AA9 4 SER C 133 GLU C 134 -1 N SER C 133 O TYR C 150 SHEET 1 AB1 4 GLU C 88 THR C 93 0 SHEET 2 AB1 4 ASN C 103 PHE C 112 -1 O ILE C 106 N LEU C 92 SHEET 3 AB1 4 PHE C 145 PHE C 153 -1 O HIS C 149 N CYS C 107 SHEET 4 AB1 4 LEU C 138 PRO C 139 -1 N LEU C 138 O ARG C 146 SHEET 1 AB2 4 LYS C 126 VAL C 128 0 SHEET 2 AB2 4 ASN C 118 ARG C 123 -1 N TRP C 121 O VAL C 128 SHEET 3 AB2 4 TYR C 161 GLU C 166 -1 O ARG C 164 N THR C 120 SHEET 4 AB2 4 LEU C 174 TRP C 178 -1 O LEU C 174 N VAL C 165 SHEET 1 AB3 4 LYS D 98 SER D 104 0 SHEET 2 AB3 4 LEU D 114 PHE D 122 -1 O SER D 118 N THR D 100 SHEET 3 AB3 4 PHE D 155 GLU D 162 -1 O THR D 157 N VAL D 119 SHEET 4 AB3 4 VAL D 142 SER D 144 -1 N VAL D 143 O MET D 160 SHEET 1 AB4 4 LYS D 98 SER D 104 0 SHEET 2 AB4 4 LEU D 114 PHE D 122 -1 O SER D 118 N THR D 100 SHEET 3 AB4 4 PHE D 155 GLU D 162 -1 O THR D 157 N VAL D 119 SHEET 4 AB4 4 ILE D 148 HIS D 149 -1 N ILE D 148 O GLN D 156 SHEET 1 AB5 4 GLN D 136 GLU D 138 0 SHEET 2 AB5 4 GLU D 128 ARG D 133 -1 N ARG D 133 O GLN D 136 SHEET 3 AB5 4 VAL D 170 GLU D 176 -1 O GLN D 174 N ARG D 130 SHEET 4 AB5 4 LEU D 184 ARG D 189 -1 O LEU D 184 N VAL D 175 SSBOND 1 CYS A 107 CYS A 163 1555 1555 2.03 SSBOND 2 CYS B 15 CYS B 79 1555 1555 2.04 SSBOND 3 CYS B 117 CYS B 173 1555 1555 2.03 SSBOND 4 CYS C 107 CYS C 163 1555 1555 2.03 SSBOND 5 CYS D 15 CYS D 79 1555 1555 2.04 SSBOND 6 CYS D 117 CYS D 173 1555 1555 2.03 LINK ND2 ASN A 78 C1 NAG A 201 1555 1555 1.44 LINK ND2 ASN A 118 C1 NAG A 202 1555 1555 1.44 LINK ND2 ASN C 78 C1 NAG C 201 1555 1555 1.43 LINK ND2 ASN C 118 C1 NAG C 202 1555 1555 1.43 LINK C ALA E 4 N CIR E 5 1555 1555 1.34 LINK C CIR E 5 N PRO E 6 1555 1555 1.30 LINK C ALA F 4 N CIR F 5 1555 1555 1.33 LINK C CIR F 5 N PRO F 6 1555 1555 1.31 CISPEP 1 ASN A 15 PRO A 16 0 -2.25 CISPEP 2 THR A 113 PRO A 114 0 0.21 CISPEP 3 TYR B 123 PRO B 124 0 2.93 CISPEP 4 ASN C 15 PRO C 16 0 1.31 CISPEP 5 THR C 113 PRO C 114 0 0.59 CISPEP 6 TYR D 123 PRO D 124 0 3.08 CRYST1 66.881 72.885 95.316 90.00 107.40 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014952 0.000000 0.004685 0.00000 SCALE2 0.000000 0.013720 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010994 0.00000